Table 2.
HR | 95% CI | p | |
---|---|---|---|
Histologic subtype | |||
AC | 1.000 (referent) | ||
ASC | 1.091 | 0.870–1.367 | 0.4509 |
Age | 1.010 | 1.009–1.012 | <0.0001 |
Gender | |||
Male | 1.000 (referent) | ||
Female | 0.951 | 0.918–0.986 | 0.006 |
Ethnicity | |||
Caucasian | 1.000 (referent) | ||
Black | 1.035 | 0.966–1.108 | 0.3290 |
Hispanic | 0.955 | 0.906–1.006 | 0.0802 |
Asian | 0.922 | 0.866–0.981 | 0.0108 |
Socioeconomic status | 0.966 | 0.953–0.980 | <0.0001 |
Clinical stage | |||
Localized | 1.000 (referent) | ||
Regional | 1.275 | 1.177–1.382 | <0.0001 |
Metastatic | 2.293 | 2.117–2.484 | <0.0001 |
Oncologic resection | |||
No | 1.000 (referent) | ||
Yes | 0.444 | 0.419–0.472 | <0.0001 |
Any radiation | |||
No | 1.000 (referent) | ||
Yes | 0.887 | 0.840–0.936 | <0.0001 |
Any chemotherapy | |||
No | 1.000 (referent) | ||
Yes | 0.508 | 0.488–0.528 | <0.0001 |
The numbers in bold are those which are statistically significant, i.e. p < 0.05
HR hazard ratio for death, 95% CI 95% confidence interval